All lobbying filings

OGR

OGR filed a Q3 report for GENENTECH INC on October 17, 2026, reporting $60,000 in lobbying income.

Lobbying for GENENTECH INC · biotechnology company

All filings by OGR · Everything GENENTECH INC has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 17, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to public health preparedness. Issues related to access to drugs for minority communities. Issues related to healthcare education and screening. Issues related to 340B Reform; H.R.9599, SECURE 340B Act. Issues related to PBM Reform.

Bills named in this filing 1

H.R. 9599
SECURE 340B Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.